These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1070 related items for PubMed ID: 19408048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW.
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [Abstract] [Full Text] [Related]

  • 3. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert CH, Pennanen M, Finch C.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G, Doksum T, Bernhardt BA, Metz SA.
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
    Schwartz MD, Hughes C, Roth J, Main D, Peshkin BN, Isaacs C, Kavanagh C, Lerman C.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
    [Abstract] [Full Text] [Related]

  • 12. Referral to cancer genetic counseling: are there stages of readiness?
    O'Neill SM, Peters JA, Vogel VG, Feingold E, Rubinstein WS.
    Am J Med Genet C Semin Med Genet; 2006 Nov 15; 142C(4):221-31. PubMed ID: 17068804
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early adoption of BRCA1/2 testing: who and why.
    Armstrong K, Weiner J, Weber B, Asch DA.
    Genet Med; 2003 Nov 15; 5(2):92-8. PubMed ID: 12644778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer.
    Alderman AK, Hawley ST, Waljee J, Mujahid M, Morrow M, Katz SJ.
    Cancer; 2008 Feb 01; 112(3):489-94. PubMed ID: 18157830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Women's perceptions of their treatment decision-making about breast cancer treatment.
    O'Brien MA, Whelan TJ, Charles C, Ellis PM, Gafni A, Lovrics P, Hasler A, Dimitry S.
    Patient Educ Couns; 2008 Dec 01; 73(3):431-6. PubMed ID: 18755565
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.